Related Experiment Video
Updated: Apr 15, 2026
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
Dual-Action Sutures: Chlorhexidine and Dexamethasone for Infection Control and Inflammation Suppression.
Brisa Guadalupe Hernández-Ramírez1, Giovanni Palomino-Vizcaino2, Lilia Angélica Hurtado-Ayala1
1Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, University Boulevard 14418, International Industrial Park Tijuana, Tijuana 22390, Mexico.
This study created a new suture releasing chlorhexidine and dexamethasone to combat surgical site infections (SSIs). The dual-drug suture showed antimicrobial properties and good biocompatibility, offering a promising approach to reduce SSIs.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Surgical Innovation
Background:
- Surgical site infections (SSIs) are a significant clinical problem.
- Bacterial adhesion and biofilm formation on sutures contribute to SSIs.
- Localized drug delivery from sutures can potentially prevent SSIs.
Purpose of the Study:
- To develop and evaluate a dual drug-eluting suture.
- To incorporate chlorhexidine (CHX) and dexamethasone (DEX) for antimicrobial and anti-inflammatory effects.
- To assess the efficacy and safety of the CHX/DEX/Lauric Acid eluting suture system.
Main Methods:
- Vicryl sutures were dip-coated with a chlorhexidine, dexamethasone, and lauric acid mixture.
- Fourier-transform infrared-attenuated total reflectance (FTIR-ATR) and High-Performance Liquid Chromatography (HPLC) were used for characterization.
- Antimicrobial activity was tested against various bacteria and yeast.
- Cell viability assays were performed to assess biocompatibility.
Main Results:
- Successful incorporation and controlled release of CHX and DEX were confirmed.
- Coated sutures maintained mechanical integrity, with no significant loss in tensile strength.
- Effective antimicrobial activity was demonstrated against Gram-positive bacteria, Gram-negative bacteria, MRSA, and Candida albicans.
- Cell viability assays showed biocompatibility with >70% cell viability.
Conclusions:
- The dual drug-eluting suture effectively delivers antimicrobial and anti-inflammatory agents locally.
- This innovative suture material shows potential for reducing surgical site infections.
- The developed suture offers a promising strategy for enhancing postoperative outcomes and patient safety.
